Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1Phase 1 1

Status

Completed 11Unknown 5Terminated 3Withdrawn 2Recruiting 2Enrolling by invitation 1Active not recruiting 1

Sponsor Class

OTHER 3INDUSTRY 2

Study Type

Interventional 3

Sponsor

Cancer Type

Gynecologic 2Tumor-Agnostic 1Other neoplasm 1

Conditions

Uterine Cervical Neoplasms 2Uterine Cervical Dysplasia 2Precancerous Conditions 1Neoplasms 1

Interventions

Cyclophosphamide 240Radiotherapy 216Gemcitabine 187Cisplatin 185Carboplatin 182Docetaxel 166Bevacizumab 166Paclitaxel 144Rituximab 141Capecitabine 141pembrolizumab 139Oxaliplatin 124Nivolumab 124Dexamethasone 122Fluorouracil 113fludarabine 103Radiosurgery 101Doxorubicin 99fludarabine phosphate 96Irinotecan 96Etoposide 95Lenalidomide 93Cytarabine 91Magnetic Resonance Spectroscopy 90Radiation 89Leucovorin 88Filgrastim 88Bortezomib 86Cetuximab 80Pemetrexed 79

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Terminated × OTHER × Colposcopy × Clear all
NCT00250055 2024-03-12

Non-Invasive, Real-Time Technology for Diagnosis of Cervical Tissue

University of New Mexico

Phase NA Terminated
100 enrolled
Tumor-Agnostic

Neoplasms

NCT00629577 2017-02-01

SAGE

British Columbia Cancer Agency

Phase 1 Terminated
50 enrolled
GynecologicOther neoplasm

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Precancerous Conditions

NCT00529464 2016-05-09

Spectroscopy Versus Standard Care in Cervical Cancer Patients

M.D. Anderson Cancer Center

Phase 3 Terminated
2 enrolled
Gynecologic

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡